Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
about
Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.Role of FoxO1 and apoptosis in pulmonary vascular remolding in a rat model of chronic thromboembolic pulmonary hypertensionThe cancer theory of pulmonary arterial hypertension.The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension.Venous thromboembolism and persistent pulmonary hypertension in cancer patients: a cross-sectional study.Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary HypertensionDasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).Discerning functional hierarchies of microRNAs in pulmonary hypertension.Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.The role of nuclear factor of activated T cells in pulmonary arterial hypertension.Epidemiology and treatment of pulmonary arterial hypertension.HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.Is pulmonary hypertension a metabolic disease?Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.MicroRNA-1 Is Decreased by Hypoxia and Contributes to the Development of Pulmonary Vascular Remodeling via Regulation of Sphingosine Kinase 1.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?]Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.
P2860
Q33614140-AA1EF061-E142-445A-BAC7-162AE80A1319Q33720107-38951047-387A-4F9E-92E9-41C0D81CBD43Q33788493-E4E99C5E-67F6-44F8-B304-A8722C5F11A6Q34924892-4161F0C8-F110-4925-867D-43056430FC30Q35779717-0ED7B294-EACD-4438-B7B3-82255E071ABCQ36352098-92B3BE49-3123-49C7-A64A-C5EEC46BE8D0Q36555793-906D5093-1F42-4232-8A4F-42B1CBDC6D3AQ36765972-52CC3206-4E19-4F56-8C9B-A2B0853C2A9AQ37217507-9C868ED8-B911-45A0-B457-46A2228C5CC7Q37555447-B5DCC056-96A8-4549-9789-7FDE13E5E8A4Q37677437-73E7FDE4-8A61-4EE0-B115-D125A9A71E2AQ38271119-C425FA26-7F91-4987-B5DE-F419459A996DQ38779774-9F1B6E5A-B8C1-43E7-A4AB-4D1C22FE08DCQ39095141-FE93F7F2-8CA9-47A3-9583-C2DB4058E4D2Q39359218-2F0B6E9C-83A1-4395-B090-7188110F452FQ39817890-1B3AAE89-7192-4D97-AE9F-B705E717F0E1Q42316663-CB78D0C9-4A0E-4740-8E26-B2E4ADA06F49Q42382006-33251D63-CB4B-400C-BF59-7F206F1441D1Q43111739-BD5C5F9A-3184-4296-8F3E-329B0B6577F6Q45019387-BB5A99A8-CFDB-4646-B883-5CD6393AC8BCQ45030673-3A7BA0C9-BEA5-4CA2-B715-EE32BF24A53EQ46183692-936EF7AF-311C-44A3-8E4E-96609F315C7FQ47426736-A0216BE6-03EA-46D6-9BFA-0E4CFC16BD2EQ47726007-FEEEE28A-B1B6-49AF-868E-E7E61D3EAF9AQ48106231-25C2125E-C7F6-4F1D-82CA-55B6E2179F5CQ48297663-9997B8F4-2A13-4DD4-9A9E-FE2295BD43B1Q49312062-5EEC4BDA-1850-46D2-B996-7B5901AEEDDEQ49471057-C6C89B99-98C3-451A-8FF2-A2CD05697901Q50969268-5855E271-03B5-4219-AE76-1BC4B1D8152DQ52312423-2481B922-CA7E-4FAF-B695-6CEC519BF528Q52889395-120E301C-7E48-4201-AA85-C6F7B1274B0DQ55112828-76EEF8CE-7366-4CC8-9CD1-A499A02EC580
P2860
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
@en
type
label
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
@en
prefLabel
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
@en
P2093
P50
P1476
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
@en
P2093
Caroline Sattler
Morane Le Hiress
Nicolas Ricard
P304
P356
10.1183/09059180.00007513
P577
2013-12-01T00:00:00Z